Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols.
Glyceryl trinitrate specifically required cysteine, whereas NaNO2 at concentrations less than 10 mM required one of several thiols or ascorbate, to activate soluble guanylate cyclase from bovine coronary artery. However, guanylate cyclase activation by nitroprusside or nitric oxide did not require the addition of thiols or ascorbate. Whereas various thiols enhanced activation by nitroprusside, none of the thiols tested enhanced activation by nitric oxide. S-Nitrosocysteine, which is formed when cysteine reacts with either NO-2 or nitric oxide, was a potent activator of guanylate cyclase. Similarly, micromolar concentrations of the S-nitroso derivatives of penicillamine, GSH and dithiothreitol, prepared by reacting the thiol with nitric oxide, activated guanylate cyclase. Guanylate cyclase activation by S-nitrosothiols resembled that by nitric oxide and nitroprusside in that activation was inhibited by methemoglobin, ferricyanide and methylene blue. Similarly, guanylate cyclase activation by glyceryl trinitrae plus cysteine, and by NaNO2 plus either a thiol or ascorbate, was inhibited by methemoglobin, ferricyanide and methylene blue. These data suggest that the activation of guanylate cyclase by each of the compounds tested may occur through a common mechanism, perhaps involving nitric oxide. Moreover, these findings suggest that S-nitrosothiols could act as intermediates in the activation of guanylate cyclase by glyceryl trinitrate, NaNO2 and possibly nitroprusside.
D000818:Animals; D001158:Arteries / Q000201:enzymology; D002417:Cattle; D003331:Coronary Vessels / Q000201:enzymology*; D006152:Cyclic GMP; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation / Q000187:drug effects*; D006162:Guanylate Cyclase / Q000378:metabolism*; D066298:In Vitro Techniques; D005996:Nitroglycerin / Q000494:pharmacology; D009603:Nitroso Compounds / Q000378:metabolism; D012977:Sodium Nitrite / Q000494:pharmacology; D013438:Sulfhydryl Compounds / Q000378:metabolism*
D009603:Nitroso Compounds; D013438:Sulfhydryl Compounds; D006162:Guanylate Cyclase; D005996:Nitroglycerin; D006152:Cyclic GMP; D012977:Sodium Nitrite